Nader S, Diamanti-Kandarakis E
This research offers further insight into this emerging safety signal, according to the study authors who noted in their Ophthalmology paper, Our novel, stratified analysis provides a more nuanced interpretation than previous pooled reviews, isolating a potential increased risk signal to observational data in the diabetes population only, a finding not corroborated by RCTs. These results are somewhat at odds with the narrative surrounding GLP-1 use and NAION risk that began in early 2024, but the researchers say they are confident in their methodology
I recommend to our customers that they put their LiPo batteries in storage mode after every run
SAVE MONEY - BUY 3 PACKS, 5 PACKS, and 25 PACKS
In simple terms, side effects are common, but only a relatively small proportion of patients stopped treatment completely because of them